ArticleActa neuropathologica2026
Comparative study of the pathology in anterior versus posterior hemispheric regions of cerebellum in essential tremor and controls.
Article in Acta neuropathologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Purkinje Cell Loss and Changes in Basket Cell Morphology in Essential Tremor and Other Cerebellar Degenerative Diseases: A Postmortem Study of 332 Brains.Cerebellum (London, England) · 2026Article
- Longitudinal Trajectories in Essential Tremor: Evidence From A Seven-Year Follow-Up of Motor and Non-Motor Symptoms.European journal of neurology · 2026Article
- Essential Tremor Cases with Subtle Cerebellar Pathology: A Systematic Study of Postmortem Cerebellar Changes.Cerebellum (London, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Essential tremor (ET), among the most common movement disorders, is characterized by 8-12 Hz action tremor of the upper extremities. Cognitive dysfunction is increasingly recognized. Postmortem studies of anterior cerebellar cortex, which plays a major role in motor function, have systematically identified morphologic changes centered on Purkinje cells (PCs) and adjacent neuronal connections, distinguishing ET from controls. However, the cerebellar cortex is compartmentalized into distinct functional anatomic regions, including control of cognition in posterior lobe. No systematic study of this posterior region has been undertaken in ET. Leveraging resources of the Essential Tremor Centralized Brain Repository, we compared the pathology across anterior and posterior hemispheric cerebellar cortices in each brain in a postmortem series of 123 brains in ET (n = 80) and controls (n = 43). We used 11 quantitative morphologic metrics that reflected PC loss, heterotopic PCs, PC dendritic changes, PC axonal changes (torpedoes, torpedo-associated and non-torpedo related), basket cell axonal hypertrophy, and climbing fiber-PC puncta changes. These metrics distinguished ET cases from controls in both anterior (11/11 metrics) and posterior regions (10/11 metrics) (p values 0.045 to < 0.0001), and 10/11 metrics demonstrated a greater burden of pathology in the ET anterior versus ET posterior cerebellar region (p values 0.045 to < 0.0001). Regional differences among controls were present to a lesser extent than in ET (6/11 metrics; p values 0.035 to < 0.0001). In a principal component analysis, these combined metrics segregated control and ET cases according to both diagnosis and cerebellar region. This is the first study to carefully document that pathology in the ET cerebellum extends beyond the anterior cerebellar region to also involve a posterior cerebellar region. In line with the prominent motor features of ET, the burden of cerebellar pathology was greater in the anterior region. These results advance our nascent understanding of the underlying neuropathological substrate of this highly prevalent disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.